Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

44.90
Delayed Data
As of May 27
 0.00 / 0.00%
Today’s Change
14.70
Today|||52-Week Range
50.11
+8.19%
Year-to-Date
3 Small Biotechs That Look Very Healthy
May 27 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close44.90
Today’s open45.21
Day’s range44.21 - 45.38
Volume309,664
Average volume (3 months)573,757
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-126.59%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,874.94%
P/E ratio5.0
Price/Sales2.95
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd+0.06+0.47%
HALOHalozyme Therapeutic...+0.11+1.11%
MCRBSeres Therapeutics I...+0.18+0.61%
NTLAIntellia Therapeutic...+0.50+1.72%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$379.8M
Annual profit (last year)$249.6M
Net profit margin65.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Lewis T. Williams
Chief Financial Officer &
Senior Vice President
Marc L. Belsky
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs